Short description
SynapDX is an early-stage laboratory services company developing blood-based diagnostic tests for the early detection of autism.
Description
SynapDx's mission is to provide laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism.
Autism Spectrum Disorders are currently estimated to affect 1 in 110 children in the United States according to the Centers for Disease Control.
SynapDx was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners.
SynapDx's corporate headquarters is located in Lexington, Massachusetts.
Total funding
$$43214321
Sign in for full access
Location
Lexington, Massachusetts, United States, North America
Founded on
January 1, 2010
Closed on
March 2, 2017
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccessforu, Absolutely Noaccess, Noway Youcantaccess, Uh Ohhhh, No Way, Uh Ohhhh
Sign in for full access
Founders
Graham Gardner, Jeffery Luber, Paul Tanico, Stanley Lapidus